EDGAR Filing Documents for 0001193125-20-220606

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-20-220606

Filing Date

2020-08-14

Accepted

2020-08-14 17:27:13

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d25139ds3.htm	S-3	440443
2	EX-1.2	d25139dex12.htm	EX-1.2	183169
3	EX-4.3	d25139dex43.htm	EX-4.3	282785
4	EX-5.1	d25139dex51.htm	EX-5.1	25863
5	EX-23.1	d25139dex231.htm	EX-23.1	2395
6	EX-23.2	d25139dex232.htm	EX-23.2	2390
7	GRAPHIC	g25139g62y98.jpg	GRAPHIC	11319
8	GRAPHIC	g25139g78y71.jpg	GRAPHIC	15176
	Complete submission text file	0001193125-20-220606.txt		964172

Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004

Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056

Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)